Population pharmacokinetics of Pseudechis porphyriacus (red-bellied black snake) venom in snakebite patients

References

• Churchman A, O'Leary MA, Buckley NA, et al. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Aust. 2010;193(11-12):696–700.
   PubMed Web of Science ®Google Scholar
• Johnston CI, Ryan NM, Page CB, et al. The Australian Snakebite Project, 2005-2015 (ASP-20). Med J Aust. 2017;207(3):119–125.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Brown SGA, Page CB, et al. Snakebite in Australia: a practical approach to diagnosis and treatment. Med J Aust. 2013;199(11):763–768.
   PubMed Web of Science ®Google Scholar
• Fry BG. Structure-function properties of venom components from Australian elapids. Toxicon. 1999;37(1):11–32.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Duffull SB, Saiao AS, et al. The pharmacokinetics of sertraline in overdose and the effect of activated charcoal. Br J Clin Pharmacol. 2015;79(2):307–315.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Hackett LP, et al. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32(3-4):571–605.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Oscarsson S, Friberg LE, et al. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther. 2009;86(4):403–410.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol. 2006;61(2):177–190.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Duffull SB. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med. 2006;32(7):1060–1065. Jul
   PubMed Web of Science ®Google Scholar
• van Gorp F, Duffull S, Hackett LP, et al. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal. Br J Clin Pharmacol. 2012;73(3):402–410.
   PubMed Web of Science ®Google Scholar
• Kulawickrama S, O'Leary MA, Hodgson WC, et al. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum [Research Support, Non-U.S. Gov't]. Toxicon. 2010;55(8):1510–1518.
   PubMed Web of Science ®Google Scholar
• NCCLS. Protocols for determination of limits of detection and limits of quantitation; approved guidelines. NCCLS document EP17-A; Pennsylvania: NCCLS; 2004.
   Google Scholar
• Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodynamics. 2001;28(5):481–504.
   PubMed Web of Science ®Google Scholar
• Hart AJ, Hodgson WC, O'Leary M, et al. Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat. Clin Toxicol. 2014;52(6):604–610.
   Web of Science ®Google Scholar
• Sanhajariya S, Duffull SB, Isbister GK. Pharmacokinetics of snake venom. Toxins. 2018;10(2):73.
   PubMed Web of Science ®Google Scholar
• Audebert F, Grosselet O, Sabouraud A, et al. Quantitation of venom antigens from European vipers in human serum or urine by ELISA [Research Support, Non-U.S]. J Anal Toxicol. 1993;17(4):236–240.
   PubMed Web of Science ®Google Scholar
• Audebert F, Sorkine M, Robbe-Vincent A, et al. Viper bites in France: clinical and biological evaluation; kinetics of envenomations [Comparative Study Research Support, Non-U.S. Hum Exp Toxicol. 1994;13(10):683–688.
   PubMed Web of Science ®Google Scholar
• Paniagua D, Jimenez L, Romero C, et al. Lymphatic route of transport and pharmacokinetics of Micrurus fulvius (coral snake) venom in sheep. Lymphology. 2012;45(4):144–153.
   PubMed Web of Science ®Google Scholar
• Audebert F, Urtizberea M, Sabouraud A, et al. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits. J Pharmacol Exp Ther. 1994;268(3):1512–1517.
   PubMed Web of Science ®Google Scholar
• Guo MP, Wang QC, Liu GF. Pharmacokinetics of cytotoxin from Chinese cobra (Naja naja atra) venom. Toxicon. 1993;31(3):339–343.
   PubMed Web of Science ®Google Scholar
• Mello SM, Linardi A, Renno AL, et al. Renal kinetics of Bothrops alternatus (Urutu) snake venom in rats. Toxicon. 2010;55(2-3):470–480.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Kinjoh K, Miyagi C, et al. Pharmacokinetics of habutobin in rabbits. Toxicon. 1995;33(9):1201–1206.
   PubMed Web of Science ®Google Scholar
• Riviere G, Choumet V, Saliou B, et al. Absorption and elimination of viper venom after antivenom administration. J Pharmacol Exp Ther. 1998;285(2):490–495.
   PubMed Web of Science ®Google Scholar
• Sim SM, Saremi K, Tan NH, et al. Pharmacokinetics of Cryptelytrops purpureomaculatus (mangrove pit viper) venom following intravenous and intramuscular injections in n rabbits. Int Immunopharmacol. 2013;17(4):997–1001.
   PubMed Web of Science ®Google Scholar
• Tan CH, Sim SM, Gnanathasan CA, et al. Pharmacokinetics of the Sri Lankan hump-nosed pit viper (Hypnale hypnale) venom following intravenous and intramuscular injections of the venom into rabbits [Research Support, Non-U.S. Toxicon. 2014;79:37–44.
   PubMed Web of Science ®Google Scholar
• Yap MK, Tan NH, Sim SM, et al. Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits. [Erratum appears in PLoS Negl Trop Dis. 2014 Sep;8(9):e3277] [Research Support, Non-U.S. Gov't]. PLoS Negl Trop Dis. 2014;8(6):e2890.
   PubMed Web of Science ®Google Scholar
• Yap MKK, Tan NH, Sim SM, et al. Toxicokinetics of Naja sputatrix (Javan spitting cobra) venom following intramuscular and intravenous administrations of the venom into rabbits. Toxicon. 2013;68:18–23.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zheng J, Jiang Z. Pharmacokinetics of thrombin-like enzyme from venom of Agkistrodon halys ussuriensis Emelianov determined by ELISA in the rat. Toxicon. 2001;39(12):1821–1826.
   PubMed Web of Science ®Google Scholar
• Tasoulis T, Isbister KG. A review and database of snake venom proteomes. Toxins. 2017;9(9):290.
   PubMed Web of Science ®Google Scholar
• Li Z, Krippendorff B-F, Shah DK. Influence of Molecular size on the clearance of antibody fragments. Pharm Res. 2017;34(10):2131–2141.
   PubMed Web of Science ®Google Scholar
• Sanhajariya S, Isbister GK, Duffull SB. The influence of the different disposition characteristics of snake toxins on the pharmacokinetics of snake venom. Toxins. 2020;12(3):188.
   Web of Science ®Google Scholar
• van Helden DF, Dosen PJ, O’Leary MA, et al. Two pathways for venom toxin entry consequent to injection of an Australian elapid snake venom. Sci Rep. 2019;9(1):8595.
   PubMedGoogle Scholar